Non-Hodgkin's Lymphoma (NHL) Clinical Trial
Official title:
Special Drug Use Investigation of Zevalin
This study is a regulatory post-marketing surveillance of Zevalin (ibritumomab tiuxetan) in Japan. In-111 Zevalin is, at first, injected to patient for gamma scan imaging to assess biodistribution of the Zevalin. When the imaging shows no altered distribution, Y-90 Zevalin is injected to the patient for the actual treatment. The objective of this study is to assess appropriateness and necessity of revision of the standardized criteria for image interpretation of In-111 Zevalin by comparing assessment by the investigator and the members of the committee for image interpretation of In-111 Zevalin. A total 40 patients will be recruited.
n/a
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01448928 -
Zevalin Post-marketing Surveillance in Japan
|
||
| Terminated |
NCT00089284 -
Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL
|
Phase 1/Phase 2 | |
| Unknown status |
NCT01983761 -
Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation
|
Phase 1/Phase 2 | |
| Recruiting |
NCT01758042 -
Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders
|
N/A | |
| Terminated |
NCT00185679 -
Haploid Allogeneic Transplant Using the CliniMACS System
|
Phase 2 | |
| Completed |
NCT01108341 -
Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL)
|
Phase 2 | |
| Completed |
NCT00129090 -
Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma
|
Phase 3 | |
| Completed |
NCT01527838 -
Single Treatment With FT1050 of an Ex-vivo Modulated Umbilical Cord Blood Unit
|
Phase 1 | |
| Completed |
NCT00614042 -
Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lymphoma
|
Phase 1 | |
| Completed |
NCT00923910 -
Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood
|
Phase 1/Phase 2 | |
| Completed |
NCT02071888 -
Study of the Glutaminase Inhibitor CB-839 in Hematological Tumors
|
Phase 1 | |
| Recruiting |
NCT04696705 -
Allogeneic γδ T Cells Immunotherapy in r/r Non-Hodgkin's Lymphoma (NHL) or Peripheral T Cell Lymphomas (PTCL) Patients
|
Early Phase 1 | |
| Completed |
NCT00889798 -
Tumor Registry of Lymphatic Neoplasia
|
||
| Terminated |
NCT05144347 -
Study of XL114 in Subjects With Non-Hodgkin's Lymphoma
|
Phase 1 |